Knowing is Half the Battle: Parsing the Global Health Value Chain

8:45 AM - 9:45 AM
Room 146A

Global health is a unique field with a set of rules that a re not necessarily known to those working in the private sector or academia. This panel will clarify these rules and elucidate the means by which a potential development opportunity is moved past the lab, through the global health value chain, and into the hands of patients.

  • Moderator: Susan Dentzer, Editor, Health Affairs
  • Orin Levine, Executive Director, International Vaccine Access Center (IVAC) 
  • Regina Rabinovich, Director, Infectious Diseases Program, Bill & Melinda Gates Foundation
  • Fred Were, Chairman, Kenya Pediatric Association


Who's Who


 

Dentzer Susan Dentzer - Susan Dentzer is the editor-in-chief of Health Affairs, the nation’s leading journal of health policy, and is an on-air analyst on health issues with the PBS NewsHour. She previously led the NewsHour’s health unit, reporting extensively on-air about health care reform debates. She is an elected member of the Institute of Medicine and the Council on Foreign Relations. Ms. Dentzer graduated from Dartmouth, is a trustee emerita of the college, and chaired the Dartmouth Board of Trustees from 2001 to 2004. She currently serves as a member of the Board of Overseers of Dartmouth Medical School and is an Overseer of the International Rescue Committee, a leading humanitarian organization. She is also on the board of directors of Research!America, an alliance working to make research to improve health a higher priority.
   
levine Orin Levine - Orin S. Levine, Ph.D., is an Associate Professor in the Department of International Health, Johns Hopkins Bloomberg School of Public Health, and Executive Director of the International Vaccine Access Center.  Dr. Levine received his undergraduate degree from Gettysburg College, and his Ph.D. in Epidemiology from Johns Hopkins Bloomberg School of Public Health.  He is an epidemiologist, trained in control and prevention of infectious diseases, especially respiratory infections in developing countries.  For over 15 years Dr. Levine has worked on efforts to accelerate the development, evaluation and introduction of new vaccines against Haemophilus influenza type B and Streptococcus pneumoniae into routine immunization programs in developing countries.  The International Vaccine Access Center aims to accelerate access to vaccines for children everywhere, through evidence-driven policy making.

Dr. Levine is also Director for Special Studies, AVI-TAC (Accelerated Vaccine Initiative-Technical Assistance Consortium), which is funded by the GAVI Alliance works to build evidence to support the use of new vaccines in GAVI-eligible countries.  Dr. Levine also serves as P.I. of the Gates Foundation funded PERCH (Pneumonia Etiology Research for Child Health) project, which aims to prepare the evidence base for pneumonia prevention from 2015 onwards.  His knowledge and expertise in the area of epidemiology places him in high demand, nationally and internationally as a consultant.  Dr. Levine’s professional memberships affirm the relevancy of his special interests.  Currently he is a Steering Committee Member of Johns Hopkins Vaccine Initiative (JHVI), Johns Hopkins Bloomberg School of Public Health and has authored over 75 peer-reviewed publications and book chapter.

   
Mshinda

Hassan Mshinda - Dr. Hassan Mshinda is the Director General of Tanzania Commission for Science and Technology in Tanzania. He completed his Master’s of Science in Applied Parasitology and Medical Technology   with University of Liverpool and PhD in Epidemiology with University of Basel in Switzerland.  Dr. Mshinda has led several research projects funded by Multilateral Initiative of Malaria in Africa, Swiss Agency for Development and Cooperation, International Atomic Energy Agency, International Development Research Centre in Canada, European Union, Ireland Aid and Novartis Foundation for Sustainable Development.  He has published several papers in communicable disease and health system. 

Dr. Mshinda has conducted several international and national consultancies assigned by Department of International Development, Danish Development Agency and World Health Organisation. Global Fund for HIV/AIDS, TB and Malaria.

Dr. Mshinda is the Chairman of INDEPTH Board, Member Scientific Coordinator of AMANET, a member of International Review Panel, Health Matrix Board Chairman St Francis Pharmacy, Board Member, BRAC Tanzania Member Regional Task Force of Maternal Newborn and Child Partnership- AFRO /WHO, Board Member National Institute for Medical Research, Board Member Tropical Pesticides Research Institute, Board Member Tanzania Industrial Research and Development, Member of Governing Board of Dar es Salaam University of College Education, member of the Medical Research Coordinating Committee.

   
Rabinovich Regina Rabinovich - Dr. Regina Rabinovich is director of the Global Health Program’s Infectious Diseases Development team. She oversees the development and implementation of strategies for the prevention, treatment, and control of diseases of particular relevance to global health, including malaria, pneumonia, diarrhea, and neglected diseases.

Prior to joining the foundation, Rabinovich served in various positions at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines. She participated in the Children's Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world, and served as liaison to the National Vaccine Program Office, focusing on vaccine safety and vaccine research. As chief of the Clinical and Regulatory Affairs Branch of the Division of Microbiology and Infectious Diseases, she managed the evaluation of candidate vaccines through a network of U.S. clinical research units. During her tenure as branch chief, the units completed large multi-center trials of pertussis and influenza vaccines as well as a number of phase I trials of platform technologies, such as an edible vaccine and vaccines for malaria and rotavirus.

In 1999, Rabinovich became director of the PATH Malaria Vaccine Initiative, a project funded by the foundation to advance efforts to develop promising malaria vaccine candidates. She serves on the boards of several organizations focused on global health and infectious diseases, including the Global Fund for AIDS, TB & Malaria; the NIAID Council; Medicines for Malaria Venture; PATH Vaccine Solutions; and the Institute of One World Health.

Rabinovich received her medical degree from Southern Illinois University and her Master of Public Health degree from the University of North Carolina in Chapel Hill. She joined NIAID's Epidemiology Training Program as a fellow in 1988.

Were Fred Were - Dr. Fred Were is a pediatrician and specialist in neonatal medicine. Dr. Were became the National Chairman of the Kenya Pediatric Association (KPA), an affiliate of the International Pediatric Association, in 2003 and holds the position to date. He has overseen the transformation of KPA into a public health-focused group. The association is currently involved in the national pediatric HIV/AIDS care project and interventions for improving newborn survival at the community level. He is also Associate Professor of newborn medicine at the University of Nairobi and Aga Khan University (Nairobi). He joined the University of Nairobi in 1994, where he still serves as a senior lecturer in the Department of Pediatrics.

Dr. Were was the principal investigator of a PneumoADIP small grants project aimed at enhancing health worker and health administrator awareness of pneumococcal disease and vaccination in Kenya. Dr. Were is a recognized expert in pediatrics and has written extensively on newborn health.